Pharma Journalist 8916 posts 0 comments

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines confirmed that the Company is in discussion with the U.S. government to purchase an…
Read More...

Ajinomoto Bio-Pharma Services  and Humanigen announced the companies will be expanding their manufacturing agreement for the fill finish supply of lenzilumab, which is one of the few…
Read More...

Eli Lilly and Company, Vir Biotechnology, Inc. and GlaxoSmithKline plc announced a collaboration to evaluate a combination of two COVID-19 therapies in low-risk patients with mild to…
Read More...

Care Access Research, a decentralized research organization (DRO) that operates as one connected team of physicians and research experts, announced a collaboration with global…
Read More...

Agenus Inc. an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and…
Read More...

AstraZeneca’s Symbicort Turbuhaler (budesonide/formoterol 160/4.5mcg) has been approved in China as an anti-inflammatory reliever to be taken as-needed in response to symptoms to…
Read More...

SMi Reports: Hear key Sessions from Amgen, BSI, FDA, Biogen, Takeda, Janssen, Merck, Alexion Pharmaceuticals, Regeneron Pharmaceuticals and many more! The two-day conference agenda…
Read More...

The fully launched MAH and priority review pathways from the NMPA (National Medical Products Administration) is stimulating new demand in China for 2021. The recently hosted CPhI…
Read More...

Mundipharma and Cidara Therapeutics  announced that the European Commission (EC) has now adopted the European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products (COMP)…
Read More...

Merck, known as MSD outside the United States and Canada, announced that the company is discontinuing development of its SARS-CoV-2/COVID-19 vaccine candidates, V590 and V591, and plans…
Read More...